Transcatheter Treatment of Mitral Regurgitation
1.4K views | +2 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Beeyond
Scoop.it!

Edwards makes another big acquisition in the transcatheter mitral valve space, this time for $690M

Edwards makes another big acquisition in the transcatheter mitral valve space, this time for $690M | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
On Monday, the structural heart company that dominates the transcatheter aortic valve replacement market in the U.S. announced that it is buying Valtech Cardio, an Israeli company for up to $690 million. Valtech Cardio has developed the Cardioband System to repair mitral and tricuspid valves using catheters.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Global Heart Valve Repair and Replacement Market is Projected to Register a Healthy CAGR of 8.1% from 2014 to 2020

Global Heart Valve Repair and Replacement Market is Projected to Register a Healthy CAGR of  8.1% from 2014 to 2020 | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Global heart valve repair and replacement market is witnessing significant growth due to growing geriatric population, change in lifestyles, and associated conditions leading to cardiovascular disorders. Moreover, technological advancements in the heart valve repair and replacement devices and surgeries, and rise in medical tourism promoting heart valve repair and replacement surgeries are also driving the market. However, there are various risks and complications associated with heart valve repair and replacement surgeries such as irregular heart rhythm, breathing problem, and embolism.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

List of new Mitral Valve patents & technologies

List of new Mitral Valve patents & technologies | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Mitral Valve - full listing of recent patents, inventions and new technologies and a free subscription to track new patents related to Mitral Valve
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Mitral Valve Repair vs Replacement

Mitral valve repair has better long-term outcomes over mitral valve replacement, says Michael Wood, MD, a cardiothoracic surgeon at MountainView Hospital. In this video, he talks about the best times for the procedure.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

2016 Medtech Company of the Year Finalists: Edwards Lifesciences

2016 Medtech Company of the Year Finalists: Edwards Lifesciences | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
A perennial top name in the medical device industry, Edwards Lifesciences continued its solid performance this year. The Irvine, CA-based company has racked up repeated wins in its transcatheter aortic valve (TAVR) business over the past several months, including CE Mark and FDA approval for expanded use of the Sapien 3 valve in intermediate risk patients. Edwards is extending the technology’s reach bit by bit; an IDE study of low-risk patients is ongoing, and Sapien 3 received regulatory approval in Japan in March.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Beyond the MitraClip: German heart surgeons successfully replace mitral valve

Beyond the MitraClip: German heart surgeons successfully replace mitral valve | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Hamburg heart surgeons are making history with new developments in minimally-invasive heart surgery. Earlier this year, heart surgeons at the Asklepios clinic Hamburg Harburg closed an auricle using new, minimally-invasive surgical techniques. More recently, in an experimental procedure, heart specialists at the University Heart Center (UHZ) in Hamburg replaced a defective mitral valve with an artificial one.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Jacksonville woman avoided open heart surgery with MitraClip heart valve device

Jacksonville woman avoided open heart surgery with MitraClip heart valve device | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
The most common form of heart valve disease, it’s a condition in which the flaps of the mitral valve do not close completely, allowing blood to flow backward into the left atrium of the heart. This makes the heart work harder and can lead to irregular heartbeat, stroke and heart failure.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

aortic and mitral heart valve repair  or replacement surgery 

aortic and mitral heart valve repair  or replacement surgery  | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Aortic or Mitral valve replacement is a cardiac surgical procedure in which a patient diseased valve is replaced by a mechanical or bioprosthetic valve.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Transcatheter Valve Procedures Gain Steam with More Populations, New Applications

Transcatheter Valve Procedures Gain Steam with More Populations, New Applications | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
In less than a decade, transcatheter aortic valve replacement (TAVR) has developed into an established procedure for restoring valve function in inoperable patients and those at high surgical risk, with promising potential for use in less-sick populations. Similarly, a percutaneous technique for mitral valve repair has been approved for clinical use, and transcatheter mitral valve replacement is now being explored.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Mitral valve disease—current management and future challenges

Mitral valve disease—current management and future challenges | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
The field of mitral valve disease diagnosis and management is rapidly changing. New understanding of disease pathology and progression, with improvements in and increased use of sophisticated imaging modalities, have led to early diagnosis and complex treatment. In primary mitral regurgitation, surgical repair is the standard of care. Treatment of asymptomatic patients with severe mitral regurgitation in valve reference centres, in which successful repair is more than 95% and surgical mortality is less than 1%, should be the expectation for the next 5 years. Transcatheter mitral valve repair with a MitraClip device is also producing good outcomes in patients with primary mitral regurgitation who are at high surgical risk.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

ACC: Still No Benefit to CABG, Mitral Valve Fix Combo

ACC: Still No Benefit to CABG, Mitral Valve Fix Combo | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Routine repair of ischemia-damaged mitral valves while doing coronary artery bypass grafting (CABG) didn't improve mid-term outcomes, longer follow-up of a randomized trial showed.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Goldman Sachs throws in $37M with Chinese replacement heart valve maker Venus Medtech

Goldman Sachs throws in $37M with Chinese replacement heart valve maker Venus Medtech | Transcatheter Treatment of Mitral Regurgitation | Scoop.it

Venus Medtech already has a transcatheter aortic valve replacement (TAVR), the A-Valve, on the market in the People’s Republic and said a pulmonary valve is in clinical trials.
The A-Valve is the only TAVR device that meets China Food & Drug Administration requirements. The Venus P-valve pulmonary replacement has already been implanted in more than 40 patients, and the current goal is to win CE Mark approval. They will reportedly be enrolling patients to accomplish this in the early half of the year.

more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Heart valve repair improves emotional wellbeing in patients with mitral regurgitation

Heart valve repair improves emotional wellbeing in patients with mitral regurgitation | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Patients with severe mitral regurgitation (MR) often suffer from psycho-emotional symptoms, such as depression and anxiety, but after undergoing mitral valve repair surgery patients experience a marked improvement in emotional and physical wellbeing, according to an article in the March 2015 issue of The Annals of Thoracic Surgery.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation

First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
David H. Adams, M.D., Cardiac Surgeon-in-Chief, Mount Sinai Health System, and his team successfully treated the first patient in the RECHORD Trial at The Mount Sinai Hospital in New York, NY. Dr. Adams, National Co-Principal Investigator of the trial, noted “the success that we observed with our first patient in the trial is very promising and is indicative of the strong clinical results observed in Europe in appropriately selected patients with degenerative mitral valve regurgitation.”
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

‘Harpoon’ device eliminates open heart surgery for mitral valve repairs

‘Harpoon’ device eliminates open heart surgery for mitral valve repairs | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
A new device may revolutionize the world of mitral valve repair, making it possible for surgeons to fix this particular heart problem without having to perform open heart surgery. According to researchers investigating the device, which is called ‘harpoon,’ it has shown 100-percent performance and safety for this medical purpose. Unlike open heart surgery, using the image-guided contraption is safer for the patient, less physically taxing, and requires much less recovery time. In fact, the researchers estimate someone could leave the hospital the day after a mitral valve repair is performed with Harpoon.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

MitraClip (TMVR) at The Center for Mitral Valve Disease

For patients with mitral valve disease unable to endure open heart surgery, the MitraClip or Transcatheter Mitral Valve Replacement (TMVR) is giving them new hope. The WVU Heart and Vascular Institute is one of only seven hospitals in the country performing this minimally invasive procedure.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty

Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
LV-MV ring size mismatch is associated with increased risk of MR recurrence. This finding may be helpful in guiding choice of ring size to prevent recurrent MR in patients undergoing MV repair and in identifying patients who may benefit from MV repair with additional subvalvular intervention or MV replacement rather than repair alone.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Investment grant to develop first transvascular mitral valve implant

Investment grant to develop first transvascular mitral valve implant | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Angel Valve Project (AVP), a spin-off from the Medical University Vienna, has been awarded €200,000 PreSeed investment from Austria Wirtschaftsservice (AWS) to develop what it says is the first transvascular catheter-deployed mitral valve implant for the heart.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Boston Scientific Issues Urgent Lotus Valve Recall

Boston Scientific Issues Urgent Lotus Valve Recall | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
The problem with the Lotus Valve was not with the valve itself, but with a component of the delivery system. A manufacturing change was made to this component in March 2016. According to Boston Scientific:
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

FDA Okays NeoChord's Degenerative Mitral Valve Regurgitation Trial

FDA Okays NeoChord's Degenerative Mitral Valve Regurgitation Trial | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
NeoChord Inc. has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Artificial Chordae Delivery System, DS1000.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Boston Scientific announces $200M option to purchase Israeli transcatheter mitral valve player

Boston Scientific announces $200M option to purchase Israeli transcatheter mitral valve player | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Boston Scientific ($BSX) announced that it has obtained an exclusive $200 million option to acquire Israel's MValve Technologies, maker of a transcatheter mitral valve replacement (TMVR) system for mitral regurgitation. Boston Scientific also said it is providing additional financing to the company in anticipation of a first in-human clinical trial. The bigwig has been financing MValve since 2012.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

All you need to know about Heart Valve Diseases

All you need to know about Heart Valve Diseases | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
The four valves of the heart are Aortic Valve, Mitral Valve, Pulmonary Valve and Tricuspid Valve. Heart value diseases are not uncommon, and seen equally in children, adults and the elderly. The heart valves lie at the exit of each of the four heart chambers. The values help in one-way blood flow through your heart. The heart ensures that the blood flows in forward direction only.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

The 50th Anniversary of the First Prosthetic Heart Valve

The 50th Anniversary of the First Prosthetic Heart Valve | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
On the 50th anniversary of the first successful prosthetic mitral valve replacement, how far has cardiac surgery come, and where are we headed? Tune in to hear Dr. Albert Starr, co-founder of the first artificial mitral valve, medical director of the Providence Heart and Vascular Institute, and director of Academic Affairs & Bioscience Development for Providence Health & Services in Portland, Oregon, recounts his first foray into the field of valvular disease and the extraordinary process of inventing the first artificial mitral valve. What complications did Dr. Starr encounter during the design process, and what breakthrough allowed for success in long-term artificial valve replacement?
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Minimally invasive mitral valve surgery offers viable option for select heart patients

Minimally invasive mitral valve surgery offers viable option for select heart patients | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery and also experience shorter hospital stays and fewer blood transfusions, according to an article posted online by The Annals of Thoracic Surgery.
more...
No comment yet.
Scooped by Beeyond
Scoop.it!

Mitral valve disease—current management and future challenges

Mitral valve disease—current management and future challenges | Transcatheter Treatment of Mitral Regurgitation | Scoop.it
Outcomes from ongoing clinical trials will greatly inform this field. Use of transcatheter techniques, both repair and replacement, is expected to substantially expand. Mitral annular calcification is an increasing problem in elderly people, causing both mitral stenosis and regurgitation which are difficult to treat. There is anecdotal experience with use of transcatheter valves by either a catheter-based approach or as a hybrid technique with open surgery, which is being studied in early feasibility trials.
more...
No comment yet.